Edition:
United States

Thermo Fisher Scientific Inc (TMO)

TMO on New York Consolidated

158.88USD
27 Sep 2016
Change (% chg)

-- (--)
Prev Close
$158.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
--
52-wk Low
--

Latest Key Developments (Source: Significant Developments)

Thermo Fisher prices offering of senior notes
Wednesday, 14 Sep 2016 04:57pm EDT 

Thermo Fisher Scientific Inc : Thermo Fisher scientific prices offering of senior notes . Priced offering of $1.2 billion aggregate principal amount of its 2.950% senior notes due 2026 at issue price of 98.787% of principal amount .Notes will pay interest on a semi-annual basis.  Full Article

FEI shareholders approve acquisition by Thermo Fisher Scientific
Tuesday, 30 Aug 2016 04:20pm EDT 

Fei Co : Fei shareholders approve acquisition by Thermo Fisher Scientific .Transaction is expected to be completed by end of 2016.  Full Article

Thermo Fisher Scientific unit issued EUR 600 mln senior notes
Tuesday, 9 Aug 2016 06:15am EDT 

Thermo Fisher Scientific Inc :Thermo fisher scientific (Finance I) B.V. issued EUR 600 million aggregate principal amount floating rate senior notes due 2018.  Full Article

Thermo Fisher Scientific reports Q2 GAAP earnings per share $1.30
Thursday, 28 Jul 2016 06:00am EDT 

Thermo Fisher Scientific Inc : Thermo fisher scientific reports second quarter 2016 results . Q2 adjusted earnings per share $2.03 . Q2 GAAP earnings per share $1.30 . Q2 revenue $4.54 billion versus I/B/E/S view $4.5 billion . Raises FY 2016 adjusted earnings per share view to $8.07 to $8.20 . Sees FY 2016 revenue $17.84 billion to $18 billion . Q2 earnings per share view $2.01 -- Thomson Reuters I/B/E/S . Fy2016 earnings per share view $8.13, revenue view $17.94 billion -- Thomson Reuters I/B/E/S .Says in Q2 of 2016, life sciences solutions segment revenue grew 13% to $1.28 billion.  Full Article

Thermo Fisher Scientific authorizes $1.5 bln of share repurchases
Thursday, 7 Jul 2016 04:30pm EDT 

Thermo Fisher Scientific Inc : Thermo fisher scientific declares quarterly dividend and authorizes $1.5 billion of share repurchases . New repurchase authorization has no expiration date. .Board of directors declared a quarterly cash dividend of $0.15 per share.  Full Article

Strata Oncology completes series A financing
Wednesday, 1 Jun 2016 08:00am EDT 

:Strata Oncology completes series A financing and signs strategic partnership with Thermo Fisher Scientific.  Full Article

Thermo Fisher to acquire FEI Company for $4.2 bln
Friday, 27 May 2016 07:00am EDT 

Thermo Fisher Scientific Inc : Thermo fisher scientific to acquire FEI Company . Deal for $4.2 billion . Deal for $107.50 per share in cash . Deal expected to be immediately accretive to adjusted earnings per share . Thermo Fisher expects to realize total synergies of about $80 million by year three following close of deal . Transaction is expected to be accretive to Thermo Fisher's adjusted EPS by $0.30 in first full year after close . JP Morgan is acting as financial advisor to Thermo Fisher, and Wachtell, Lipton, Rosen & Katz is serving as legal counsel . Expects to realize total synergies of approximately $80 million by year three following close of deal .Intends to use proceeds from committed debt financing and cash on hand to fund transaction..  Full Article

Enzo Biochem reaches settlement with unit of Thermo Fisher
Monday, 16 May 2016 04:07pm EDT 

Enzo Biochem Inc : Settlement does not affect unit's action brought in federal district court in new haven, ct against life technologies' predecessors . Settlement resolves dispute between enzo life sciences and life technologies impacts only one of 11 cases originally brought by enzo . Resolved suit is one of 11 infringement cases brought in delaware federal district court; seven remain pending .Enzo biochem's life sciences unit reaches $35 million patent infringement settlement in delaware with life technologies corporation.  Full Article

Thermo Fisher Scientific Inc raises FY 2016 guidance
Thursday, 28 Apr 2016 06:00am EDT 

Thermo Fisher Scientific Inc:Raises its revenue and adjusted EPS guidance for FY 2016 to reflect inclusion of Affymetrix results for nine months, a less adverse foreign exchange environment, additional stock buybacks completed in the first quarter and stronger operational performance.Raises revenue guidance to new range of $17.86 to $18.04 billion versus its original guidance of $17.36 to $17.56 billion announced in Jan. 2016.Raises adjusted EPS guidance to a new range of $8.05 to $8.19 versus the $7.80 to $7.96 previously communicated, for 9 to 11 percent growth over FY 2015.  Full Article

Thermo Fisher Scientific Inc prices offering of senior notes
Monday, 4 Apr 2016 05:30pm EDT 

Thermo Fisher Scientific Inc:Says priced an offering of $1.0 billion aggregate principal amount of 3.000% senior notes due 2023 at an issue price of 99.512% of the principal amount.Says Issuance of the notes is expected to close on or about April 13, 2016.Plans to use the net proceeds of the offering and cash on hand to redeem all of the outstanding $1.0 billion aggregate principal amount of its 2.250% senior notes that mature on August 15, 2016.Joint book-running managers for the offering are Merrill Lynch, Pierce, Fenner & Smith Incorporated; Goldman, Sachs & Co. and Morgan Stanley & Co. LLC.  Full Article

BRIEF-Thermo Fisher prices offering of senior notes

* Priced offering of $1.2 billion aggregate principal amount of its 2.950% senior notes due 2026 at issue price of 98.787% of principal amount